alexa Epidemiology and unmet needs in hypertension.
Cardiology

Cardiology

Journal of Hypertension: Open Access

Author(s): Flack JM

Abstract Share this page

Abstract BACKGROUND: The persistent control of blood pressure (BP) to levels below current recommended levels is an important but often elusive goal for patients with hypertension. OBJECTIVE: To provide an overview of unmet needs in contemporary hypertension treatment. SUMMARY: The rationale for BP normalization is very persuasive. Incrementally higher BP levels predict higher rates of microvascular (e.g., retinopathy, stroke, nephropathy) and macrovascular disease (e.g., myocardial infarction), as well as organ (e.g., heart) failure. Accordingly, the pharmacologic reduction of BP levels with a broad range of mechanistically dissimilar agents reduces the risk of these BP-related complications. The primary prevention of BP-related complications has been closely linked to the magnitude of decreases in BP brought about pharmacologically, but some modest disease-specific differences have been noted between drug classes. However, pharmacologic blockade of the renin-angiotensin aldosterone system in high-risk patients (e.g., patients with diabetic nephropathy) reduces the risk of BP-related renal end points more than treatment strategies that do not include these agents, even when BP levels are lowered to similar degrees. CONCLUSION: Despite the large number of antihypertensive agents available, the majority of patients with hypertension who are treated with drugs do not attain goal BP levels. Though the reasons for this are complex and relate to various factors for patients, providers, and systems of medical care delivery, new pharmacologic treatments hold the potential to augment the reduction of BP levels while minimizing class-specific side effects. This article was published in J Manag Care Pharm and referenced in Journal of Hypertension: Open Access

Relevant Expert PPTs

Relevant Speaker PPTs

Recommended Conferences

  • 3rd International Conference on Hypertension and Healthcare
    Tokyo , Japan
  • 4th International Conference on Hypertension & Healthcare
    Zurich, Switzerland
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords